GB2067900B - Medicinal tablets - Google Patents

Medicinal tablets

Info

Publication number
GB2067900B
GB2067900B GB8101082A GB8101082A GB2067900B GB 2067900 B GB2067900 B GB 2067900B GB 8101082 A GB8101082 A GB 8101082A GB 8101082 A GB8101082 A GB 8101082A GB 2067900 B GB2067900 B GB 2067900B
Authority
GB
United Kingdom
Prior art keywords
medicinal tablets
medicinal
tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8101082A
Other versions
GB2067900A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DDSA Pharmaceuticals Ltd
Original Assignee
DDSA Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DDSA Pharmaceuticals Ltd filed Critical DDSA Pharmaceuticals Ltd
Priority to GB8101082A priority Critical patent/GB2067900B/en
Publication of GB2067900A publication Critical patent/GB2067900A/en
Application granted granted Critical
Publication of GB2067900B publication Critical patent/GB2067900B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
GB8101082A 1980-01-25 1981-01-14 Medicinal tablets Expired GB2067900B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB8101082A GB2067900B (en) 1980-01-25 1981-01-14 Medicinal tablets

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8002574 1980-01-25
GB8101082A GB2067900B (en) 1980-01-25 1981-01-14 Medicinal tablets

Publications (2)

Publication Number Publication Date
GB2067900A GB2067900A (en) 1981-08-05
GB2067900B true GB2067900B (en) 1983-06-22

Family

ID=26274280

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8101082A Expired GB2067900B (en) 1980-01-25 1981-01-14 Medicinal tablets

Country Status (1)

Country Link
GB (1) GB2067900B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403360D0 (en) * 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical compositions
EP0181966A1 (en) * 1984-11-13 1986-05-28 Gist-Brocades N.V. Compression-coated dispersible tablets
EP0199855A1 (en) * 1985-05-02 1986-11-05 Gist-Brocades N.V. Tablets comprising tromethoprim and a sulfonamide
EP0200252B1 (en) * 1985-05-02 1999-03-10 Yamanouchi Europe B.V. Tablets comprising trimethoprim and a sulfonamide
FR2766089B1 (en) * 1997-07-21 2000-06-02 Prographarm Lab IMPROVED MULTIPARTICULAR TABLET WITH RAPID DELIVERY
US6177421B1 (en) * 1999-05-04 2001-01-23 Fuisz International Ltd. Amoxicillin and clavulanate composition
CN105769883A (en) * 2014-12-17 2016-07-20 康普药业股份有限公司 Compound sulfamethoxazole dispersible tablet and preparation method thereof
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Also Published As

Publication number Publication date
GB2067900A (en) 1981-08-05

Similar Documents

Publication Publication Date Title
DE3172028D1 (en) Pharmaceutical formulation
IL63880A0 (en) Medicament containing 2-amino-6-trifluoromethoxy-benzothiazole
JPS57128622A (en) Nitroglycerin medicine medicine
PH25637A (en) Dipyridamole-containing pharmaceutical form
ZA813465B (en) Pharmaceutical composition
DE3175541D1 (en) Dosage units
GB2090185B (en) Tablet press
GB8428369D0 (en) Pharmaceutical tablets
GB8315489D0 (en) Stable pharmaceutical tablet
JPS5759804A (en) Alkalline analgesic capsule
JPS56139420A (en) Drug
GB2067900B (en) Medicinal tablets
ZA817443B (en) Tablet dispenser
GB2074028B (en) Pharmaceutical formulations
ZA818221B (en) Pharmaceutical compounds
MTP884B (en) Pharmaceutical preparationes
DE3176849D1 (en) Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate
SG62587G (en) Pharmaceutical formulation
AU87660S (en) Pharmaceutical tablet
JPS57171916A (en) Non-effusible chewable high-lipid-content tablets
ZA815175B (en) Pharmaceutical composition
PH18681A (en) Methoxsalem dosage forms
GB2105886B (en) Pill counter
CA47464S (en) Tablet
CA50538S (en) Pharmaceutical tablet

Legal Events

Date Code Title Description
746 Register noted 'licences of right' (sect. 46/1977)
PCNP Patent ceased through non-payment of renewal fee